special populations | CARLAT PUBLISHING

Interpreting Assessment Discrepancies from Multiple Sources

October 17, 2022

In this episode, we will discuss why assessment discrepancies arise, how we can manage them, and what these discrepancies tell us about a patient’s symptoms and response to treatment.

EXPERT Q&A

QT Intervals in Psychiatric Practice

October 1, 2022

Victoria Hendrick, MD and Paul Barkopoulos, MD.

Paul Barkopoulos, MD. Clinical Assistant Professor, Psychiatry & Biobehavioral Sciences, UCLA David Geffen School of Medicine and Olive View UCLA Medical Center, Los Angeles, CA.

Victoria Hendrick, MD. Editor-in-Chief, The Carlat Hospital Psychiatry Report; Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Dr. Barkopoulos and Dr. Hendrick, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Several psychiatric medications prolong the QTc interval and place patients at risk of the dreaded torsade de pointes. Some patients are particularly vulnerable to QTc prolongation: the elderly, patients with heart disease and electrolyte imbalances, and patients taking certain medications, like thioridazine and ziprasidone. We provide a step-by-step guide so that you can keep your patients safe from this cardiovascular side effect.

RESEARCH UPDATE

Less Sleep Correlated with Dementia

October 1, 2022

Talya Shahal, MD.

Talya Shahal, MD. Dr. Shahal, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This study supports an association between short sleep duration in middle life and an increasedrisk of dementia.

RESEARCH UPDATE

Can Pimavanserin Treat Psychosis in Patients With Dementia?

October 1, 2022

James Black, MD

James Black, MD. Dr. Black, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This study suggests that patients started on pimavanserin for dementia and psychosis should probably continue it to prevent relapse, but we will need more data for clarity given flaws in the study design.

RESEARCH UPDATE

Do White Matter Hyperintensities Predict Memory Loss with Electroconvulsive Therapy?

October 1, 2022

Dax Volle, MD

Dax Volle, MD. Dr. Volle, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

We can continue to recommend ECT to patients with severe white matter hyperintensities and cognitive impairment, as cognition seems to return to baseline following ECT.

EXPERT Q&A

Assessing Suicide Risk in the Older Adult

October 1, 2022

Yeates Conwell, MD

Professor, vice-chair, and co-director at the Center for the Study and Prevention of Suicide and director of the geriatric psychiatry program, University of Rochester, NY. Director, Office for Aging Research and Health Services, University of Rochester Medical Center.

Dr. Conwell, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Dr. Yeates Conwell discusses how to assess suicide risk and provides examples on how to intervene.

How to Interview the Older Patient

August 29, 2022

Stephanie Collier, MD and Rehan Aziz, MD.

The expanding population of older adults has created a need for all clinicians to participate in their care. Interviewing techniques require adaptation in older adults, such as accounting for hearing or vision impairment and speaking slowly and clearly. This podcast will cover additional factors to consider when evaluating older patients.

EXPERT Q&A

Personality Changes Later in Life: Diagnostic and Treatment Considerations

July 1, 2022

Rajesh R. Tampi, MD, MS, DFAPA.

Rajesh R. Tampi, MD

Professor and chairman, Department of Psychiatry, Bhatia Family Endowed Chair in Psychiatry, Creighton University School of Medicine. Catholic Health Initiatives (CHI) Behavioral Health Services, Omaha, NE.

Dr. Tampi, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Dr. Rajesh R. Tampi describes the course of personality disorders as patients age and provides documentation tips for clinicians who suspect personality disorders.

RESEARCH UPDATE

Topiramate Improves Weight in Schizophrenia in South Asians

June 1, 2022

Brian Miller, MD, PhD, MPH.

Brian Miller, MD, PhD, MPH. Dr. Miller has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This study looked at adjunctive topiramate for weight in a patient population inherently more vulnerable to cardiometabolic disturbance.

Race and Psychiatry

May 9, 2022

Kali Cyrus MD, MPH, Chris Aiken, MD, and Kellie Newsome, PMHNP

To start a conversation about race, you need to know the lingo. We interview psychiatrist Kali Cyrus on internalized racism, microaggressions, implicit bias, and more.